印度医药行情

CLINICAL TRIALS INDIA	RMB 8,500
India is fast-emerging as an attractive destination for clinical trials. Today, the market value of clinical research outsourced to India is estimated at US$100 million. A clinical trial is a costly as well as time-consuming process. The cost of conducting clinical trials for a specific drug ranges between US$350 and US$500 million. Now about 20 organizations in India specialize in clinical trails. These companies have the skills to comply with standards such as ICH-GCP guidelines. Currently, 20 to 30 per cent of the clinical development activity is outsourced to Clinical Research Organizations (CROs) in developing countries such as India due to lower costs. The cost of conducting clinical trials in India ranges between 20 and 60 per cent of the cost in western countries. According to industry sources, a volunteer in a developing country is paid between US$70 and US$350, based on the nature of the study, for participating in three studies a year. By contrast, volunteers in western countries are paid relatively higher amounts. ...... More
GLOBAL PHARMACEUTICALS	RMB 8,500
It is the best of times and worst of times. The global pharmaceutical industry made a series of scientific breakthroughs that enriched our lives. Companies turned problems that troubled mankind for centuries into opportunities. Drugs that fight obesity and impotence have turned out to bestsellers. Shepherding these drugs from the laboratory to the neighborhood drug store has not been an easy job. Pharmaceutical companies had to crash through knowledge barriers, navigate regulatory minefields and overcome marketing challenges for making these drugs a reality. On the flip side of the coin, healthcare funding is snowballing into a major issue in the Developed countries. Poor countries, meanwhile, are having troubling accessing essential drugs in the first place. Quietly nibbling away at the foundations of our society are killer diseases like Aids. Indeed the times are heady, but equally formidable are the challenges....... More
INDIAN PHARMACEUTICALS	RMB 8,500
Indian pharmaceutical industry is at a crossroads. Come January, 2005, a new era will unfold in the history of Indian pharmaceutical industry. Introduction of product patents will pull the curtains down on a golden age for Indian pharmaceutical companies. An age where a regulatory system focused on process patents allowed Indian companies to mint money by producing cheaper versions of blockbuster drugs through alternative processes. From purely an Indian perspective, lack of intellectual property rights laid the foundation for a strong domestic industry. Inadequate intellectual property rights together rigid price controls have also brought drug prices within the reach of a common man. Now, with product patents around the corner, Indian pharmaceutical industry and its participants finds themselves at a fork in history. A time that calls for tough decisions on issues ranging from research priorities to regional focus. The decisions that Indian companies, multinationals and government now make will determine the future size, shape and structure of Indian pharmaceutical industry—and impact the price and range of drugs available to Indian consumers.......More
INDIAN PHARMA COMPANIES	RMB 8,500
Globally, pharmaceutical industry grew at a compounded annual growth rate (CAGR) of 9.1 per cent in the last 23 years to US$491bn—powered by a string of innovative blockbusters. It is an industry characterized by huge investments in drug discovery and development. In the recent past, falling research productivity triggered off a series of mega mergers. Multinationals fixated upon mergers and acquisitions as a way of fattening their research pipelines. This at best represents a short term solution. Multinationals are trying to raise research productivity by pursuing contract research opportunities and striking alliances with biotech companies and academe. With a slew of blockbuster drugs losing patent protection in the next few years and government’s pressing for pharmaceutical price cuts, multinationals today find themselves under more immense pressure to find new drugs and slash costs....... More
GLOBAL BIOTECHNOLOGY	RMB 8,500
Biotechnology industry is still at its infancy stage and it has not unleashed its entire potential. However it is consistently enriching lives and industry through innovations and breakthroughs. Traditional standards to identify industry do not hold true in biotechnology industry due to the very nature of the industry. This industry is classified on the basis of their processes rather than output. Besides many research based companies are having revenue stream based on their research and not the product output. Biotechnology industry is taking up its shape gradually, first it has introduced in healthcare and second raked into agriculture. It has started taking the third step into other industries collectively clubbed under the umbrella of bioindustry. It is possible because of biological processes and their products are best factories to synthesize compounds of human needs........ More
GLOBAL CHEMICALS	RMB 8,500
Chemicals touch every part of our lives. They are everywhere from salt on the table to the teflon coating on pots and pans to fertilizer in the soil to the air above the soil, everything is a mix and match of atoms and molecules. No wonder, the chemical industry is often called the keystone industry because it is the source of raw materials for most industries. Global chemical industry excluding pharmaceuticals is worth US$1185 billion. North American market accounts for nearly 22 per cent of the market while Europe has a share of 45 per cent. Asia pacific, meanwhile, has a share of about 26 per cent. Among countries, US is the largest producer of chemicals on the globe. Broadly, chemical industry includes commodity chemicals, specialty and fine chemicals, agrochemical and fertilizers, and finally industrial gases. Commodity chemicals is of course the largest with a share of 52 per cent, followed by specialty and fine chemicals with a share of 35 per cent, and agrochemical and fertilizers with 9 per cent. The balance four per cent share is accounted by industrial gases....... More
GLOBAL OIL & GAS	RMB 8,500
Oil and gas industry meets two-thirds of primary energy needs. It powers automobiles, run power plants and provides building blocks for petrochemicals. The discovery of oil reserves in Middle East has bestowed economic prosperity on almost all its constituent countries. A similar wealth creation story is likely to unfold in Russia and Kazakhstan. It all started in a small way in 1859 when American Industrialist George Bissel hired Colonel Edwin Drake to find the source of oil seeps in Western Pennsylvania. Drake dug a well near oil creek in Pennsylvania struck oil and laid the foundation for oil and gas industry. From such humble beginnings, the industry grew in size and complexity. Now daily oil production runs into millions of barrels. In a short span of time, oil has gone from a commodity to a strategic good that decides the economic fate of nations. If the Arab oil embargo of the early seventies revealed the extent of our dependence on oil, the uproar and panic over the recent upsurge in oil prices showed that little has changed over the last three decades....... More